Search Results

There are 4555 results for: content related to: Pharmacokinetics of two common antiretroviral regimens in older HIV -infected patients: a pilot study

  1. Are all non-thymidine analogue backbones appropriate for treating antiretroviral – naïve patients?

    International Journal of Clinical Practice

    Volume 59, Issue 12, December 2005, Pages: 1452–1458, L. J. Waters and M. R. Nelson

    Version of Record online : 18 NOV 2005, DOI: 10.1111/j.1368-5031.2005.00711.x

  2. You have full text access to this OnlineOpen article
    p16INK4a, a Senescence Marker, Influences Tenofovir/Emtricitabine Metabolite Disposition in HIV-Infected Subjects

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 6, Issue 2, February 2017, Pages: 120–127, JB Dumond, JW Collins, ML Cottrell, CR Trezza, HMA Prince, C Sykes, C Torrice, N White, S Malone, R Wang, KB Patterson, NE Sharpless and A Forrest

    Version of Record online : 26 DEC 2016, DOI: 10.1002/psp4.12150

  3. You have full text access to this OnlineOpen article
    Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women

    The Journal of Clinical Pharmacology

    Volume 55, Issue 6, June 2015, Pages: 629–638, Rebecca N. Burns, Craig W. Hendrix and Ayyappa Chaturvedula

    Version of Record online : 4 FEB 2015, DOI: 10.1002/jcph.461

  4. Pharmacologic Opportunities for HIV Prevention

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 5, November 2010, Pages: 598–609, M R Nicol and A D M Kashuba

    Version of Record online : 29 SEP 2010, DOI: 10.1038/clpt.2010.189

    Corrected by:

    Corrigendum: CORRIGENDUM: Pharmacologic Opportunities for HIV Prevention

    Vol. 90, Issue 2, 343, Version of Record online: 29 JUN 2011

  5. Design of tenofovir–UC781 combination microbicide vaginal gels

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 5, May 2012, Pages: 1852–1864, Patrick F. Kiser, Alamelu Mahalingam, Judit Fabian, Eric Smith, Festo R. Damian, Jennifer J. Peters, David F. Katz, Hoda Elgendy, Meredith R. Clark and David R. Friend

    Version of Record online : 22 FEB 2012, DOI: 10.1002/jps.23089

  6. American Society for Clinical Pharmacology and Therapeutics

    Clinical Pharmacology & Therapeutics

    Volume 101, Issue S1, February 2017, Pages: S5–S99,

    Version of Record online : 13 JAN 2017, DOI: 10.1002/cpt.570

  7. You have free access to this content
    Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903

    HIV Medicine

    Volume 7, Issue 7, October 2006, Pages: 442–450, NA Margot, B Lu, A Cheng, MD Miller and the Study 903 Team

    Version of Record online : 22 AUG 2006, DOI: 10.1111/j.1468-1293.2006.00404.x

  8. You have full text access to this OnlineOpen article
    Linking the Population Pharmacokinetics of Tenofovir and Its Metabolites With Its Cellular Uptake and Metabolism

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 3, Issue 11, November 2014, Pages: 1–6, K Madrasi, R N Burns, C W Hendrix, M J Fossler and A Chaturvedula

    Version of Record online : 12 NOV 2014, DOI: 10.1038/psp.2014.46

  9. Evaluation of Atazanavir and Darunavir Interactions with Lipids for Developing pH-Responsive Anti-HIV Drug Combination Nanoparticles

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 8, August 2014, Pages: 2520–2529, Jinghua Duan, Jennifer P. Freeling, Josefin Koehn, Cuiling Shu and Rodney J. Y. Ho

    Version of Record online : 19 JUN 2014, DOI: 10.1002/jps.24046

  10. An intravaginal ring for the simultaneous delivery of multiple drugs

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 8, August 2012, Pages: 2833–2843, Marc M. Baum, Irina Butkyavichene, Joshua Gilman, Sean Kennedy, Etana Kopin, Amanda M. Malone, Cali Nguyen, Thomas J. Smith, David R. Friend, Meredith R. Clark and John A. Moss

    Version of Record online : 22 MAY 2012, DOI: 10.1002/jps.23208

  11. You have free access to this content
    Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women

    British Journal of Clinical Pharmacology

    Volume 80, Issue 5, November 2015, Pages: 1031–1041, Maïlys De Sousa Mendes, Deborah Hirt, Saik Urien, Elodie Valade, Naïm Bouazza, Frantz Foissac, Stephane Blanche, Jean-Marc Treluyer and Sihem Benaboud

    Version of Record online : 22 JUL 2015, DOI: 10.1111/bcp.12685

  12. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 4, April 2012, Pages: 1423–1435, Anthony S. Ham, Shweta R. Ugaonkar, Lianjun Shi, Karen Watson Buckheit, Howard Lakougna, Umadevi Nagaraja, Garry Gwozdz, Laurie Goldman, Patrick F. Kiser and Robert W. Buckheit Jr.

    Version of Record online : 6 JAN 2012, DOI: 10.1002/jps.23026

  13. An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile

    HIV Medicine

    P Kumar, YS Lakshmi and AK Kondapi

    Version of Record online : 21 DEC 2016, DOI: 10.1111/hiv.12475

  14. You have free access to this content
    British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy

    HIV Medicine

    Volume 4, Issue S1, October 2003, Pages: 1–41, BHIVA Writing Committee on behalf of the BHIVA Executive Committee

    Version of Record online : 26 SEP 2003, DOI: 10.1046/j.1468-1293.4.s1.3.x

  15. Mitochondrial and Oxidative Stress Response in HepG2 Cells Following Acute and Prolonged Exposure to Antiretroviral Drugs

    Journal of Cellular Biochemistry

    Volume 116, Issue 9, September 2015, Pages: 1939–1946, Savania Nagiah, Alisa Phulukdaree and Anil Chuturgoon

    Version of Record online : 23 JUL 2015, DOI: 10.1002/jcb.25149

  16. You have free access to this content
    Discussed Poster Abstracts

    Fundamental & Clinical Pharmacology

    Volume 31, Issue S1, April 2017, Pages: 21–50,

    Version of Record online : 30 MAR 2017, DOI: 10.1111/fcp.12272

  17. You have free access to this content
    Poster abstracts

    HIV Medicine

    Volume 7, Issue s1, April 2006, Pages: 11–38,

    Version of Record online : 9 OCT 2008, DOI: 10.1111/j.1464-2662.2006.00375.x

  18. You have free access to this content
    Poster Abstracts

    HIV Medicine

    Volume 16, Issue s2, April 2015, Pages: 12–77,

    Version of Record online : 20 APR 2015, DOI: 10.1111/hiv.12265

  19. Non-nucleoside reverse transcriptase inhibitors: a review

    International Journal of Clinical Practice

    Volume 61, Issue 1, January 2007, Pages: 105–118, L. Waters, L. John and M. Nelson

    Version of Record online : 8 JAN 2007, DOI: 10.1111/j.1742-1241.2006.01146.x

  20. You have free access to this content
    Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 116–124, Fabien Zoulim and Stephen Locarnini

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12069